Skip to main content
. 2021 Jul 23;11:15051. doi: 10.1038/s41598-021-94504-x

Figure 1.

Figure 1

Changes over time periods in terms of disease evolution time, Charlson comorbidity index, DAS28, use of TNFi and monotherapy according to diagnosis. First- and second-line biological treatment trends are shown.